I guess all drugs for NASH, but I am more optimistic that something at some point will emerge - but not a guarantee. FXR stands as good a chance as any MOA to be a part of soemthing that might come out for NASH, probably as combination, but any individual drug or even class remains more of a long shot IMO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.